Structure Therapeutics In... (GPCR)
NASDAQ: GPCR
· Real-Time Price · USD
25.52
-1.30 (-4.85%)
At close: May 09, 2025, 3:59 PM
26.49
3.80%
After-hours: May 09, 2025, 05:01 PM EDT
-4.85% (1D)
| Bid | 25.12 |
| Market Cap | 487.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -122.53M |
| EPS (ttm) | -2.34 |
| PE Ratio (ttm) | -10.91 |
| Forward PE | -12.66 |
| Analyst | Buy |
| Ask | 28.5 |
| Volume | 524,438 |
| Avg. Volume (20D) | 973,822 |
| Open | 26.65 |
| Previous Close | 26.82 |
| Day's Range | 25.52 - 27.11 |
| 52-Week Range | 13.22 - 62.74 |
| Beta | -1.79 |
About GPCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GPCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GPCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+1.03%
Structure Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
9 months ago
-1.15%
Shares of weight loss stocks are trading lower, possibly on continued weakness following recent weight loss data from Roche, which could cause competition concerns for companies in the space.
1 month ago · seekingalpha.com
Structure: A Lot Riding On Next Data Readout For Oral GLP-1 CandidateStructure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, al...
